These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17675361)

  • 21. Recovery from neuromuscular block after an intubation dose of cisatracurium and rocuronium in lumbar disc surgery.
    Hans P; Welter P; Dewandre PY; Brichant JF; Bonhomme V
    Acta Anaesthesiol Belg; 2004; 55(2):129-33. PubMed ID: 15264506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intubating conditions and neuromuscular block after divided dose mivacurium or single dose rocuronium.
    Patel N; Kamath N; Smith CE; Pinchak AC; Hagen JH
    Can J Anaesth; 1997 Jan; 44(1):49-53. PubMed ID: 8988824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Monitoring of neuromuscular block and prevention of residual paralysis].
    Fuchs-Buder T; Meistelman C
    Ann Fr Anesth Reanim; 2009 Sep; 28 Suppl 2():S46-50. PubMed ID: 19887277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Org 25969 (sugammadex), a selective relaxant binding agent for antagonism of prolonged rocuronium-induced neuromuscular block.
    Shields M; Giovannelli M; Mirakhur RK; Moppett I; Adams J; Hermens Y
    Br J Anaesth; 2006 Jan; 96(1):36-43. PubMed ID: 16357116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuromuscular monitoring and postoperative residual curarisation: a meta-analysis.
    Naguib M; Kopman AF; Ensor JE
    Br J Anaesth; 2007 Mar; 98(3):302-16. PubMed ID: 17307778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Neuromuscular rest blockades after a single dose of a mid-term muscle relaxant].
    Schreiber JU
    Anaesthesist; 2004 Oct; 53(10):1006-8. PubMed ID: 15205835
    [No Abstract]   [Full Text] [Related]  

  • 27. Reversal of prolonged rocuronium neuromuscular blockade with sugammadex in an obstetric patient with transverse myelitis.
    Weekes G; Hayes N; Bowen M
    Int J Obstet Anesth; 2010 Jul; 19(3):333-6. PubMed ID: 20627694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence and duration of residual paralysis at the end of surgery after multiple administrations of cisatracurium and rocuronium.
    Maybauer DM; Geldner G; Blobner M; Pühringer F; Hofmockel R; Rex C; Wulf HF; Eberhart L; Arndt C; Eikermann M
    Anaesthesia; 2007 Jan; 62(1):12-7. PubMed ID: 17156221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of neuromuscular effects, efficacy and safety of rocuronium and atracurium in ambulatory anaesthesia.
    Whalley DG; Maurer WG; Knapik AL; Estafanous FG
    Can J Anaesth; 1998 Oct; 45(10):954-9. PubMed ID: 9836032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What rules of thumb do clinicians use to decide whether to antagonize nondepolarizing neuromuscular blocking drugs?
    Videira RL; Vieira JE
    Anesth Analg; 2011 Nov; 113(5):1192-6. PubMed ID: 21865491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reversal of rocuronium-induced (1.2 mg kg-1) profound neuromuscular block by accidental high dose of sugammadex (40 mg kg-1).
    Molina AL; de Boer HD; Klimek M; Heeringa M; Klein J
    Br J Anaesth; 2007 May; 98(5):624-7. PubMed ID: 17347184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Case-Based Management of Neuromuscular Block, Reversal, and Recovery: Ensuring Optimal Outcomes.
    AANA J; 2015 Dec; Suppl():4-15. PubMed ID: 26749974
    [No Abstract]   [Full Text] [Related]  

  • 33. Successful management of rocuronium-induced anaphylactic reactions with sugammadex: a case report.
    Kawano T; Tamura T; Hamaguchi M; Yatabe T; Yamashita K; Yokoyama M
    J Clin Anesth; 2012 Feb; 24(1):62-4. PubMed ID: 22154092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anaphylactic shock to neuromuscular blocking agent: a familial history.
    Duvaldestin P; Wigdorowicz C; Gabriel I
    Anesthesiology; 1999 Apr; 90(4):1211-2. PubMed ID: 10201697
    [No Abstract]   [Full Text] [Related]  

  • 35. Cardiorespiratory arrest: a grade IV delayed anaphylactic reaction in the recovery room caused by rocuronium.
    Sedó G; Cabañas R; Fiandor A; Del Pozo V; Cancelliere N; Prior N; López-Serrano MC; Quirce S
    J Investig Allergol Clin Immunol; 2013; 23(3):204-5. PubMed ID: 23967762
    [No Abstract]   [Full Text] [Related]  

  • 36. Findings of the neuromuscular blocking agent rocuronium in blood from deceased subjects several months after exposure: A report of two cases.
    Frost J; Gundersen POM; Brede WR; Gjerde S; Pleym H; Slørdal L
    Forensic Sci Int; 2023 Jun; 347():111680. PubMed ID: 37062138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Repeat dosing of rocuronium 1.2 mg kg-1 after reversal of neuromuscular block by sugammadex 4.0 mg kg-1 in anaesthetized healthy volunteers: a modelling-based pilot study.
    Cammu G; de Kam PJ; De Graeve K; van den Heuvel M; Suy K; Morias K; Foubert L; Grobara P; Peeters P
    Br J Anaesth; 2010 Oct; 105(4):487-92. PubMed ID: 20630888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sugammadex, a new reversal agent for neuromuscular block induced by rocuronium in the anaesthetized Rhesus monkey.
    de Boer HD; van Egmond J; van de Pol F; Bom A; Booij LH
    Br J Anaesth; 2006 Apr; 96(4):473-9. PubMed ID: 16464982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rocuronium anaphylaxis in a 3-year-old girl with no previous exposure to neuromuscular blocking agents.
    Choi SH; Yi JW; Rha YH
    Asian Pac J Allergy Immunol; 2013 Jun; 31(2):163-6. PubMed ID: 23859417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recovery from prolonged deep rocuronium-induced neuromuscular blockade: A randomized comparison of sugammadex reversal with spontaneous recovery.
    Rahe-Meyer N; Berger C; Wittmann M; Solomon C; Abels EA; Rietbergen H; Reuter DA
    Anaesthesist; 2015 Jul; 64(7):506-12. PubMed ID: 26126940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.